{
    "pmcid": "8907979",
    "qa_pairs": {
        "How were the nanobodies targeting SARS-CoV-2 isolated in the study?": [
            "A Bactrian camel was immunized with the SARS-CoV-2 RBD to generate a VHH phage display library.",
            "A llama was immunized with the full SARS-CoV-2 virus to create a diverse antibody library.",
            "A mouse model was used to produce hybridoma cells secreting nanobodies against the SARS-CoV-2 spike protein.",
            "A humanized yeast display system was employed to screen for nanobodies binding to the SARS-CoV-2 nucleocapsid protein."
        ],
        "What are the structural advantages of nanobodies compared to conventional antibodies?": [
            "Nanobodies are smaller and lack light chains, allowing them to access epitopes inaccessible to larger antibodies.",
            "Nanobodies have a larger size and more complex structure, enabling them to bind to multiple epitopes simultaneously.",
            "Nanobodies contain additional light chains, increasing their binding specificity to viral proteins.",
            "Nanobodies have a unique double-chain structure that enhances their stability in acidic environments."
        ],
        "What future modification is suggested to enhance the efficacy of the nanobody heterodimer?": [
            "Fusing the heterodimer to a human IgG1 Fc domain to improve serum half-life and engage Fc-mediated functions.",
            "Incorporating additional light chains to increase binding affinity to the SARS-CoV-2 spike protein.",
            "Engineering the heterodimer to include a fluorescent tag for better visualization in cellular assays.",
            "Adding a polyethylene glycol (PEG) moiety to increase solubility and reduce immunogenicity."
        ],
        "What was the primary method used to confirm the high-affinity binding of the selected nanobodies to the SARS-CoV-2 RBD?": [
            "Surface plasmon resonance (SPR) analysis.",
            "Enzyme-linked immunosorbent assay (ELISA).",
            "Western blot analysis.",
            "Flow cytometry."
        ],
        "Which nanobody heterodimer demonstrated the most potent neutralization across all tested SARS-CoV-2 variants of concern?": [
            "The P2C5-P5F8 heterodimer.",
            "The P2G1-P5F8 heterodimer.",
            "The P2C5-P2G1 heterodimer.",
            "The P5F8-P2G1 heterodimer."
        ]
    }
}